LOS ANGELES
Schedule
3:00p 5:00p | ARRIVAL AND REGISTRATION |
5:00p 8:00p | WELCOME RECEPTION, COCKTAIL MIXER, APPETIZERS, ENTERTAINMENT, AND PRESENTATIONS |
08:00a 09:00a | REGISTRATION AND CONTINENTAL BREAKFAST |
09:00a 09:15a | WELCOME AND INTRODUCTION |
09:15a 09:45a | OPENING SESSION KEYNOTE ADDRESS WHAT IS ARTHROFIBROSIS, WHAT ARE THE CAUSES, AND HOW IS IT TREATED? |
10:45a 11:15a | SCREENING FOR ARTHROFIBROSIS AFTER ANTERIOR CRUCIATE LIGAMENT RE-CONSTRUCTION: ANALYSIS OF ASSOCIATION WITH HUMAN LEUKOCYTE ANTIGEN. |
11:15a 11:45a | POTENTIAL ARTHROFIBROSIS CANCER TGF-B1 LINK |
11:45a 12:15p | HEPATITIS AND ARTHROFIBROSIS SPECIAL LUNCHEON SPEAKER |
12:15p 12:45p | WHEN DRUG RESEARCH IS PERSONAL: THE IMPORTANCE OF PATIENT ADVOCACY IN DRUG DEVELOPMENT AND INNOVATION |
12:45p 01:00p | BREAK |
01:00p 01:30p | OCCUPATIONAL AND ENVIRONMENTAL CAUSES OF ARTHROFIBROSIS |
01:30p 02:15p | ROUNDTABLES: QUESTIONS AND ANSWERS WITH THE EXPERTS |
02:15p 02:30p | CLOSING REMARKS Special Guest Speaker |
02:30p 06:30p | PATIENT DOCTOR MEET + GREET |
06:30p 10:00p | NETWORKING COCKTAILS, DINNER, AND ENTERTAINMENT |
08:00a 09:00a | REGISTRATION AND CONTINENTAL BREAKFAST |
09:00a 09:15a | WELCOME INTRODUCTION |
09:15a 09:45a | RESEARCH, THERAPIES, AND THE DRUG PIPELINE |
09:45a 10:15a | MENISCUS TRANSPLANTATION: INDICATIONS, TECHNIQUES, CLINICAL OUTCOMES. |
10:15a 10:45a | VISIT EXHIBITS |
10:45a 11:15a | THE FINAL STAGES OF ARTHROFIBROSIS |
11:15a 11:45a | TOOLS FOR LIVING BETTER WITH ARTHROFIBROSIS |
11:45a 12:00p | EFFECTIVE ADVOCACY FOR ARTHROFIBROSIS |
12:00p 01:00p | LUNCH |
01:00p 01:15p | THE ROLE OF THE US FDA IN THE PROCESS OF DRUG DEVELOPMENT |
01:15p 01:30p | US FOOD AND DRUG ADMINISTRATION — PATIENT-FOCUSED DRUG DEVELOPMENT PROGRAM |
01:30p 02:30p | ROUNDTABLES: QUESTIONS AND ANSWERS WITH THE EXPERTS |
02:30p 02:40p | CLOSING REMARKS |
02:40p 06:00p | VISIT EXHIBITS |
06:30p 10:00p | NETWORKING COCKTAILS, DINNER, AND ENTERTAINMENT |
09:00a 05:00p | VISIT EXHIBITS IRRADIATION IN THE TREATMENT OF ARTHROFIBROSIS AFTER TOTAL KNEE ARTHROPLASTY: A PRELIMINARY TRIAL |
Prevention of arthrofibrosis after anterior cruciate ligament reconstruction using the central third patellar tendon autograft.
Arthrofibrosis of the knee following ligament surgery.
Knee Surgery: Complications, Pitfalls, and Salvage.
Prevention of arthrofibrosis by monoclonal antibody against vascular endothelial growth factor.